{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418521216014720.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/sj.bjc.6604953"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/6604953.pdf"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/6604953"}}],"dc:title":[{"@value":"CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418521216014721","@type":"Researcher","foaf:name":[{"@value":"E Marangoni"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521216014720","@type":"Researcher","foaf:name":[{"@value":"N Lecomte"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521216014723","@type":"Researcher","foaf:name":[{"@value":"L Durand"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521216014851","@type":"Researcher","foaf:name":[{"@value":"G de Pinieux"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521216014722","@type":"Researcher","foaf:name":[{"@value":"D Decaudin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521216014848","@type":"Researcher","foaf:name":[{"@value":"C Chomienne"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521216014850","@type":"Researcher","foaf:name":[{"@value":"F Smadja-Joffe"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418521216014849","@type":"Researcher","foaf:name":[{"@value":"M-F Poupon"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00070920"},{"@type":"EISSN","@value":"15321827"}],"prism:publicationName":[{"@value":"British Journal of Cancer"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2009-02-24","prism:volume":"100","prism:number":"6","prism:startingPage":"918","prism:endingPage":"922"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://www.nature.com/articles/6604953.pdf"},{"@id":"http://www.nature.com/articles/6604953"}],"createdAt":"2009-02-24","modifiedAt":"2023-05-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360572092711464960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gastric Cancer Stem Cells: Current Insights into the Immune Microenvironment and Therapeutic Targets"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/sj.bjc.6604953"},{"@type":"CROSSREF","@value":"10.3390/biomedicines8010007_references_DOI_HHW4dcbN8gdju84b2zCHfRjAFbb"}]}